e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Animal models of allergic airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Decreased Smad7 expression in the airways of a mouse model of chronic asthma
M. Ota, H. Sagara, G. Cheng, K. Akimoto, K. Sugiyama, T. Okada, A. Nakao, T. Fukuda (Mibu, Kofu, Japan)
Source:
Annual Congress 2004 - Animal models of allergic airway disease
Session:
Animal models of allergic airway disease
Session type:
Oral Presentation
Number:
4023
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ota, H. Sagara, G. Cheng, K. Akimoto, K. Sugiyama, T. Okada, A. Nakao, T. Fukuda (Mibu, Kofu, Japan). Decreased Smad7 expression in the airways of a mouse model of chronic asthma. Eur Respir J 2004; 24: Suppl. 48, 4023
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001
Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007
Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002
HDAC6 inhibition and deletion reduce COPD symptoms in mice and human airway epithelia
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020
Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Reduced bronchial epithelial Smad7 protein expression in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 3s
Year: 2005
ST2 gene knockout attenuates allergic airways disease
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002
Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011
Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003
Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002
Influence of CpG-oligodeoxynucleotides and dexamethasone on remodeling and expression of MMP-9 in murine model of chronic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006
Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept